Dr. Jason and Dr. Jarvis are experts in Epidemiology, Infectious Diseases, HIV/AIDS, Pediatrics, Immunology, Infection Control, Hospital Infections, Patient Safety, Healthcare Epidemiology, Blood Product Safety, Medical Device Safety, Health Communications, and Public Health

Jason and Jarvis Associates, LLC was formed by two senior physician-scientists, following 23 years of research, policy making, and teaching at the U.S. Centers for Disease Control and Prevention (CDC), as officers in the U.S. Public Health Service. Drs. Jason and Jarvis were also on the faculty of Emory University School of Medicine during that time period.

Drs. Jason and Jarvis provide assistance in: research study design, analysis, and review; development and conduct of surveys and epidemiologic studies; preparation and review of manuscripts and educational associated materials; national and international medical and public health program development and evaluation; healthcare facility infection control program development or evaluation; and teaching and educational presentations.  Both review medical charts and related materials and act as medical experts on select legal cases. Both physicians are able to travel. Fee schedules and full curriculum vitae are available upon request.

How to get in touch with us

Dr. Jason:
Cell phone — 404-483-1830
Email — jjason@post.harvard.edu

Dr. Jarvis:
Cell phone — 404-512-4777
Email — WRJMJ@aol.com

Dr. Jason

Dr. Jason is a highly respected expert in epidemiology, immunology, infectious diseases, HIV/AIDS, pediatrics, and health communications.

Dr. Jason spent 23 years as an officer in the U.S. Public Health Service (PHS), medical scientist at the U.S. Centers for Disease Control and Prevention (CDC), and Clinical Associate Professor at Emory University School of Medicine.  She has numerous peer-reviewed publications, served on CDC’s Institutional Review Board, and has advised State, federal agencies, and international organizations.  She is currently a consultant to the U.S. Food and Drug Administration (FDA)’s Medical Devices Advisory Committee and Center for Devices and Radiological Health.


Dr. Jarvis

Dr. Jarvis is an acknowledged world leader in healthcare-associated (nosocomial) infection control. He is a highly published expert in infectious diseases, infection control, epidemiology, public health, and pediatrics.

Dr. Jarvis has published over 500 peer-reviewed publications, book chapters, and editorials on these topics.

Dr. Jason’s Areas of Expertise


including estimations of the incidence, prevalence, and costs associated with various diseases; design, execution, analysis, and interpretation of clinical and epidemiologic studies and outbreaks; and surveillance


including vaccines, vaccine-related injuries, immunodeficiency, immunotherapy, and translating basic science articles for investors and corporate executives

infectious diseases

including human immunodeficiency virus (HIV);  hepatitis viruses, e.g., hepatitis A (HAV), B (HBV) and C (HCV); herpes viruses, e.g., herpes simplex virus (HSV); Cronobacter; methicillin-sensitive and -resistant staphylococcus aureus (MSSA and MRSA); antimicrobial-resistant organisms; Legionella; tick-borne infections; and opportunistic infections

needlestick injuries, bloodborn infections, and medical device-related infections

bloodborne infections, blood product-related infections, and medical device-associated infections/safety

transmission of HIV, HCV, and other organisms in and outside of healthcare settings

advising investors and corporate executives,

especially in regard to immunotherapies, vaccines, HIV, and HCV.  Please note this is done only on an ongoing basis, not as a one-time or short-term consultant.

infant feeding,

infant mortality, child abuse and parenting

health communication

especially in terms of HIV infection, infant feeding and associated risks, and risk assessment in general

Dr. Jarvis’s Areas of Expertise

antimicrobial-resistant bacterial infections

esp. methicillin-resistant Staphylococcus aureus [MRSA], vancomycin-resistant enterococcus [VRE], vancomycin intermediate-resistant or resistant S. aureus [VISA or VRSA]

national surveillance systems

National Nosocomial Infections Surveillance [NNIS] system, now known as the National Healthcare Safety Network [NHSN]